Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: July 25, 2024
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer.
Journal: Oncotarget
Published: March 19, 2024
Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement.
Journal: Journal of the American College of Surgeons
Published: October 23, 2023
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer.
Journal: Breast cancer research and treatment
Published: January 24, 2023
Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA Mutation.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 09, 2021
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 14, 2021
Integrating poly(ADP-ribose) polymerase (PARP) inhibitors in the treatment of early breast cancer.
Journal: Current opinion in oncology
Published: February 22, 2019
Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 15, 2018
Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 05, 2018
Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 11, 2017
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.
Journal: NPJ genomic medicine
Published: August 19, 2017
Last Updated: 09/26/2026